PathCision Medicine Featured in Harvard Innovation Labs' "AI-Powered Innovation"

March 2, 2026

PathCision Medicine is proud to be recognized in the Harvard Innovation Labs’ “AI-Powered Innovation” feature. The article highlights PathCision’s AI-driven discovery engine and its mission to transform drug development. By integrating machine learning with tissue pathology, PathCision is discovering and developing therapeutics optimized for the tumor microenvironment, aiming to maximize drug efficacy while minimizing toxicity for patients.

This recognition underscores the company’s commitment to advancing the next generation of tissue-informed medicines.

Read the full article here: Harvard Innovation Labs - AI-Powered Innovation